SRLS Seracare Life Sciences (MM)

Levi & Korsinsky is investigating the Board of Directors of SeraCare Life Sciences, Inc. (“SeraCare” or the “Company”) (NASDAQ: SRLS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to an affiliate of Linden Capital Partners. Under the terms of the transaction, SeraCare shareholders will receive $4.00 per share. The transaction has a total approximate value of $82 million.

Click here to learn how to join the action: http://www.zlk.com/seracare-life-srls, or call: 877-363-5972.

The investigation concerns whether the SeraCare Board of Directors is adequately shopping the Company and working to obtain the best price possible for SeraCare shareholders. In particular, SeraCare stock traded as high as $4.15 per share as recently as July 19, 2011. Furthermore, at least one analyst set a price target for SeraCare stock at $5.00 per share.

If you own common stock in SeraCare and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com.

Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C. The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024